NPEX disclosed risks around dependence on future financing, possible disappointing profitability, and dependence on major customers; no public layoffs, shutdown, or acquisition signal was found.
SourceWe help nurses in nursing homes to be 30% more effective
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Dutch healthtech scale-up building BedSense and the Momo App for nursing homes and memory-care communities: an under-mattress sensor plus caregiver app that surfaces who needs attention, reduces false alarms/falls, and supports more efficient night-shift care [Official site][YC][NPEX].
Primary product
BedSense under-mattress sensor + Momo App caregiver dashboard
Founded
2017
Headquarters
Delft, South Holland, Netherlands
Team size
100-150
Work style
Hybrid
Industry
Hospitals and Health Care
Sub-industry
nursing home care technology
Offices
0 jobs at Momo Medical
Check back later for new openings
Business model
Stage
Series A
Total raised
$9M
Latest round
Series A · Sep 2024
Latest amount
$6.5M
Sep 2024 · PGGM and NextGen
Sep 2024 · European Regional Development Fund
Jun 2024
Mar 2023 · AWS Healthcare Accelerator
Sep 2021 · Y Combinator
Nov 2018 · Fundis
Leadership
Head of CareTeams
Commercial Lead
Teamlead Germany
Lead Software Development
Team Lead - Product Discovery & Process Management
Founders
Co-founder, former CEO & Co-Founder
Investors
Versatile, enthusiastic, international, hands-on, curious, supportive, challenging, simple, and fun; strongly mission-driven around improving care quality and making caregivers' work easier.
Work style
Hybrid
Compensation
Public job ads show roughly €4,300-€5,300/month for medior full-stack roles and €5,200-€6,200/month for senior roles on 40 hours, plus 8% holiday allowance; embedded roles show €4,300-€5,100/month medior and €5,000-€6,000/month senior, plus pension, travel reimbursement, and 30 vacation days.
Benefits
Pricing
Subscription for healthcare organizations; public pages also mention a 3-month free trial and a paid Package+ add-on.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Reported 2024 net sales were about €4.0M; third-party ARR estimates range from roughly $11.7M to $32.4M.
Estimated monthly visits
3.3K
NPEX disclosed risks around dependence on future financing, possible disappointing profitability, and dependence on major customers; no public layoffs, shutdown, or acquisition signal was found.
SourceLifesciences @ Work · May 2026
Highlights the company’s origin story, product pivot, and reported growth from about 25 employees in 2019 to around 150 in 2026.
NPEX · Mar 2025
Profiles Menno Gravemaker’s path from TU Delft to Momo Medical, including the pivot from hospital pressure-ulcer prevention to nursing-home workflow software.
NPEX · Sep 2024
Announces €6.5M growth financing led by PGGM and NextGen, with Jay Searson, UNETI Ventures, and the Centre for Aging + Brain Health Innovation also participating; notes a €0.5M ERDF subsidy and cites Vilans time-savings data.
Silicon Canals · Sep 2024
Explains how the new capital will support Dutch scale-up plans, international expansion, and a doubling of supported beds to 30,000; reiterates the company’s growth and patient-safety impact.
PGGM · Sep 2024
Official press release on the round, investor mix, 30,000-bed target, and international rollout to Germany, Canada, and the US.